Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × rhenium-SSS-lipiodol × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatocellular Carcinoma Non-resectable 1

Interventions

pembrolizumab 460 Carboplatin 327 Specimen Handling 325 Magnetic Resonance Spectroscopy 287 Cisplatin 286 Nivolumab 273 Cyclophosphamide 260 Paclitaxel 229 Radiotherapy 216 Biopsy 200 Gemcitabine 191 Bevacizumab 183 Dexamethasone 151 durvalumab 145 Rituximab 144 Capecitabine 137 atezolizumab 136 Oxaliplatin 136 Docetaxel 135 Fluorouracil 133 venetoclax 130 Ipilimumab 121 Drug Therapy 120 Etoposide 119 Doxorubicin 113 Prednisone 111 Lenalidomide 109 Radiosurgery 104 Leucovorin 98 Pemetrexed 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05797870 2026-03-19

Lip-Re2

Center Eugene Marquis

Phase 2 Suspended

Gastrointestinal

Hepatocellular Carcinoma Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡